Chunlan Pu

607 total citations
32 papers, 434 citations indexed

About

Chunlan Pu is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Chunlan Pu has authored 32 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Organic Chemistry. Recurrent topics in Chunlan Pu's work include Protein Degradation and Inhibitors (13 papers), Ubiquitin and proteasome pathways (9 papers) and Peptidase Inhibition and Analysis (7 papers). Chunlan Pu is often cited by papers focused on Protein Degradation and Inhibitors (13 papers), Ubiquitin and proteasome pathways (9 papers) and Peptidase Inhibition and Analysis (7 papers). Chunlan Pu collaborates with scholars based in China, Netherlands and United States. Chunlan Pu's co-authors include Rui Li, Guoyi Yan, Xueyan Hou, Suke Lan, Shirui Wang, Xinyu Ma, Meng Zhou, Hongjia Zhang, Jianyou Shi and Rui Deng and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Chunlan Pu

30 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chunlan Pu China 14 285 136 81 54 54 32 434
Ju-Hwa Kim South Korea 13 295 1.0× 239 1.8× 27 0.3× 31 0.6× 14 0.3× 14 448
Shiyong Fan China 14 265 0.9× 262 1.9× 31 0.4× 112 2.1× 12 0.2× 43 667
Junmei Hou China 5 302 1.1× 109 0.8× 44 0.5× 35 0.6× 39 0.7× 5 502
Ralf Häfer Germany 7 165 0.6× 158 1.2× 29 0.4× 24 0.4× 48 0.9× 13 417
Nannan Liu China 10 149 0.5× 90 0.7× 35 0.4× 29 0.5× 8 0.1× 23 425
Greta Klejborowska Poland 11 154 0.5× 32 0.2× 116 1.4× 96 1.8× 8 0.1× 19 333
Adrian Begaye United States 5 133 0.5× 134 1.0× 11 0.1× 64 1.2× 15 0.3× 6 387
Thierry Louat Belgium 14 347 1.2× 75 0.6× 15 0.2× 114 2.1× 55 1.0× 22 617
Julie Chen United States 7 232 0.8× 59 0.4× 26 0.3× 57 1.1× 20 0.4× 10 467

Countries citing papers authored by Chunlan Pu

Since Specialization
Citations

This map shows the geographic impact of Chunlan Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunlan Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunlan Pu more than expected).

Fields of papers citing papers by Chunlan Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chunlan Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunlan Pu. The network helps show where Chunlan Pu may publish in the future.

Co-authorship network of co-authors of Chunlan Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Chunlan Pu. A scholar is included among the top collaborators of Chunlan Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chunlan Pu. Chunlan Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pu, Chunlan, et al.. (2025). Taxus chinensis-Derived Nanovesicles Alleviate Mouse Colitis by Inhibiting Inflammatory Cytokines and Restoring Gut Microbiota. Journal of Inflammation Research. Volume 18. 5611–5625.
3.
Pu, Chunlan, et al.. (2024). Enhancing therapeutic efficacy in homologous recombination-proficient pancreatic cancer via the combination of PARP1-PROTAC and a BRD4 inhibitor. Bioorganic & Medicinal Chemistry. 115. 117970–117970. 4 indexed citations
4.
Luo, Dan, Rong‐Hua Luo, Weilin Wang, et al.. (2024). Discovery of L15 as a novel Vif PROTAC degrader with antiviral activity against HIV-1. Bioorganic & Medicinal Chemistry Letters. 111. 129880–129880. 9 indexed citations
5.
Yang, Wenyong, et al.. (2024). Identification and clinical validation of diverse cell-death patterns-associated prognostic features among low-grade gliomas. Scientific Reports. 14(1). 11874–11874. 1 indexed citations
6.
Liu, Jianyu, et al.. (2024). Recent advances in dual PROTACs degrader strategies for disease treatment. European Journal of Medicinal Chemistry. 279. 116901–116901. 8 indexed citations
7.
Tang, Jiao, et al.. (2024). Research progress of BRD4 in head and neck squamous cell carcinoma: Therapeutic application of novel strategies and mechanisms. Bioorganic & Medicinal Chemistry. 113. 117929–117929. 2 indexed citations
8.
9.
Wang, Shirui, Dan Luo, Chunlan Pu, et al.. (2023). Discovery of the GSH responsive “Y-PROTACs” targeting ALK and CDK4/6 as a potential treatment for cancer. European Journal of Medicinal Chemistry. 248. 115082–115082. 20 indexed citations
10.
Pu, Chunlan, Yuanyuan Liu, Rui Deng, et al.. (2023). Development of PROTAC degrader probe of CDK4/6 based on DCAF16. Bioorganic Chemistry. 138. 106637–106637. 24 indexed citations
11.
Huang, Qing, Chunlan Pu, Shirui Wang, et al.. (2022). Synthesis and biological evaluation of a novel c-Myc inhibitor against colorectal cancer via blocking c-Myc/Max heterodimerization and disturbing its DNA binding. European Journal of Medicinal Chemistry. 243. 114779–114779. 4 indexed citations
12.
Pu, Chunlan, et al.. (2022). Anti-fibrotic effect of extracellular vesicles derived from tea leaves in hepatic stellate cells and liver fibrosis mice. Frontiers in Nutrition. 9. 1009139–1009139. 14 indexed citations
13.
Pu, Chunlan, Yu Tong, Yuanyuan Liu, et al.. (2022). Selective degradation of PARP2 by PROTACs via recruiting DCAF16 for triple-negative breast cancer. European Journal of Medicinal Chemistry. 236. 114321–114321. 34 indexed citations
14.
Pu, Chunlan, Shirui Wang, Dan Luo, et al.. (2022). Synthesis and biological evaluation of a tumor-selective degrader of PARP1. Bioorganic & Medicinal Chemistry. 69. 116908–116908. 17 indexed citations
15.
Zhong, Xin-Xin, Rong‐Hua Luo, Guoyi Yan, et al.. (2021). Lead optimization to improve the antiviral potency of 2-aminobenzamide derivatives targeting HIV-1 Vif-A3G axis. European Journal of Medicinal Chemistry. 224. 113680–113680. 3 indexed citations
16.
Yan, Guoyi, Xin-Xin Zhong, Chunlan Pu, et al.. (2021). Targeting Cysteine Located Outside the Active Site: An Effective Strategy for Covalent ALKi Design. Journal of Medicinal Chemistry. 64(3). 1558–1569. 9 indexed citations
17.
Ma, Xinyu, Guoyi Yan, Xin-Xin Zhong, et al.. (2021). Discovery of a novel covalent CDK4/6 inhibitor based on palbociclib scaffold. European Journal of Medicinal Chemistry. 219. 113432–113432. 12 indexed citations
18.
Yan, Guoyi, Xin-Xin Zhong, Yue Lin, et al.. (2021). Discovery of a PROTAC targeting ALK with in vivo activity. European Journal of Medicinal Chemistry. 212. 113150–113150. 41 indexed citations
19.
Liu, Lei, et al.. (2013). The Safety and Efficacy of Laparoscopic Donor Nephrectomy for Renal Transplantation: An Updated Meta-analysis. Transplantation Proceedings. 45(1). 65–76. 52 indexed citations
20.
He, Linhong, Chunlan Pu, Hong Yang, Dan Zhao, & Anping Deng. (2009). Development of a polyclonal indirect ELISA with sub-ng g −1 sensitivity for the analysis of clenbuterol in milk, animal feed, and liver samples and a small survey of residues in retail animal products. Food Additives & Contaminants Part A. 26(8). 1153–1161. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ju-Hwa Kim Breakdown of academic impact, for papers by Shiyong Fan Breakdown of academic impact, for papers by Junmei Hou Breakdown of academic impact, for papers by Ralf Häfer Breakdown of academic impact, for papers by Nannan Liu Breakdown of academic impact, for papers by Greta Klejborowska Breakdown of academic impact, for papers by Adrian Begaye Breakdown of academic impact, for papers by Thierry Louat Breakdown of academic impact, for papers by Julie Chen
Rankless by CCL
2026